Bioglandin 500mcg Injection

Overview Bioglandin 500mcg Injection

Indomethacin 500mcg injection is administered to manage patent ductus arteriosus (PDA), a congenital cardiac anomaly affecting infants. This medication enhances circulatory function in newborns, aiding in PDA closure. Administration is strictly via injection by a healthcare professional and should never be self-administered. Commonly reported adverse effects include temporary cessation of breathing (apnea) and brief, low-grade fever (transient pyrexia). Report any adverse reactions, including those not listed here, to your physician. Indomethacin 500mcg injection is suitable for infants requiring treatment for PDA following appropriate medical evaluation. Pre-treatment assessments are standard practice. However, withhold administration and seek immediate medical attention should your infant exhibit allergic symptoms like wheezing, dyspnea, facial swelling, urticaria, or cutaneous erythema. Always consult your doctor for any concerns.

Uses of Bioglandin 500mcg Injection

Managing a Patent Ductus Arteriosus (PDA)

Major Benefits of Bioglandin 500mcg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Bioglandin 500mcg Injection:

• Apnea (absence of breathing)
• Fever

How to use Bioglandin 500mcg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Bioglandin 500mcg Injection works:

Bioglandin 500mcg Injection mimics the effects of prostaglandin E1, a naturally occurring compound, by enhancing circulation in neonates with congenital cardiac anomalies.

What if you forget to take Bioglandin 500mcg Injection :

Should you forget a scheduled Bioglandin 500mcg Injection, seek your physician's advice.